JPMorgan Starts Ardent Health Partners Inc (ARDT) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
Truist Securities Starts Ardent Health Partners Inc (ARDT) at Buy
August 12, 2024 6:20 AM EDTTruist Securities analyst David MacDonald initiates coverage on Ardent Health Partners Inc (NYSE: ARDT) with a Buy rating and a price target of $21.00.
The analyst comments "Leading hospital operator and provider of HC services across 6 states and 8 markets, providing care through a... More
